Delivery Order SPE2DB24D8002-SPE2DB24FJMZP

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMZP
    Delivery Order

This federal contract award, valued at $4,370.30, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. This appears to be a stand-alone delivery order contract, not associated with a larger contract vehicle. The contract has a firm fixed-price pricing structure and does not utilize a set-aside designation. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. This award demonstrates the company's capability to reliably supply critical medical products, including prescription medications, to support U.S. Armed Forces medical operations through the DLA's medical supply chain programs.

Generated 12/23/24, 2:29 PM